Sunday, Apr 30 2017 | Time 22:14 Hrs(IST)
image
  • Prez poll: JD(U) trying to form anti-BJP front
  • Joshna is Asian champion, Max Lee takes men's title
  • Civilian injured in firing by gunmen in south Kashmir
  • Odisha Governor Jamir says if he asked to serve, he would
  • Union MoS Piyush Goyal to visit Nagaland tomorrow
  • Divyanga pension hiked to Rs 500 per month in UP
  • Cyclone and heavy rains predicted, alert issued for 13 districts in Bihar
  • 2 held, 40 semi-automatic pistols recovered
  • Nadal eases to 10th Barcelona Open title
  • Turkish President arrives, talks likely on trade, NSG membership
  • Assam Rifles nabs 2 NSCN-K cadres in Nagaland
  • Four injured in bomb explosion at the residence of JD(U) MP Kahkasha Praveen
  • Rains lash HP, Keylong receive fresh snowfall
  • -------
  • CPI plans a series of agitation in Bihar on land reforms and unemployment
Science & Technology Share

MedGenome launches liquid biopsy blood test 'Oncotrack' for cancer detection in patients

MedGenome launches liquid biopsy blood test 'Oncotrack' for  cancer detection in patients

Mumbai, Mar 8 (UNI) MedGenome, the country's premier Genomics-based research and diagnostics company, has launched 'Oncotrack', the liquid biopsy blood test, for cancer recurrence detection and monitoring.
The Oncotrack is a non-invasive screening test that is set to transform the way physicians in India can identify genetic alterations, interpret, assess and treat various forms of cancers.
Launching the blood test yesterday, Chief operation officer of MedGenome, Dr V L Ramprasad said, 'Liquid biopsy has the capacity to interpret infinite mutations which will pave the way for new drug discovery, research and therapies.
Over 35 oncologists in India have already screened patients using our Oncotrack.
Further, since it has a very patient-friendly approach, we are confident it will be very well accepted by both the doctors and patients.
' India is likely to have over 1.
73 million new cases of cancer and over 8,80,000 deaths due to the disease by 2020.
Around 70 per cent of all cancer patients approach the doctor when the disease has advanced, and the chances of cure are very low.
'Management of cancer will undergo a massive transformation in India with NGS-based liquid biopsies.
We are constantly striving to get the most advanced genetic testing technology/ technique at affordable prices to the patients and Oncotrack is one such offering,' said Sam Santhosh, chairman, MedGenome.
The test, developed entirely by MedGenome, is the only one to be validated in India and verified from samples of cancer patients from across the country.
The test screens the samples by analyzing cell-free DNA that is isolated from the patients’ blood.
Using high-end sequencing technology, the screening process identifies specific gene mutations that are linked with Melanoma, Lung and Colon cancers.
The test facilitates detection of mutation where there is difficulty of obtaining biopsy or in the event of a damaged biopsy material and non-availability of tissue biopsy.
This offers oncologists the power to look for actionable alterations in a patient's treatment, management, without having to do an invasive biopsy or where biopsy is not an option.
Oncotrack is a proven molecular tool after histopathology diagnosis and detecting molecular changes at baseline and at the time of relapse in lung and colon cancer for deciding the right treatment.
The test has been validated in a scientific study, in academic collaboration with Tata Memorial Hospital -- Dr Kumar Prabhash, medical oncologist, and Dr Amit Dutt, principal investigator (Scientist F) at ACTREC, Tata Memorial Centre.
UNI ST SS RSA SB 1043

International

International conference on healthcare on May 4

Pune, Apr 28 (UNI) A three-day international conference on healthcare will be held at the Lavale campus of Symbiosis International University (SIU) from May 4.

International

International conference on healthcare on May 4

Pune, Apr 28 (UNI) A three-day international conference on healthcare will be held at the Lavale campus of Symbiosis International University (SIU) from May 4.

Parents

Parents over 50 yrs lack strength to realise unfulfilled dreams: Abbott’s Survey

Mumbai, Apr 27 (UNI) Indian parents above 50 years of age lack strength to fulfill their dreams, a survey released by Abott nutrition, a subsidiary of healthcare major Abbott Labs, said.

Parents

Parents over 50 yrs lack strength to realise unfulfilled dreams: Abbott’s Survey

Mumbai, Apr 27 (UNI) Indian parents above 50 years of age lack strength to fulfill their dreams, a survey released by Abott nutrition, a subsidiary of healthcare major Abbott Labs, said.

Bengal

Bengal Govt to launch app on blood donors

Kolkata, Apr 25 (UNI) To ensure information about availability of blood is available at one’s fingertips, the Bengal Health Department and the State AIDS Prevention and Control Society (SACS) have come together to create an innovative app.

Bengal

Bengal Govt to launch app on blood donors

Kolkata, Apr 25 (UNI) To ensure information about availability of blood is available at one’s fingertips, the Bengal Health Department and the State AIDS Prevention and Control Society (SACS) have come together to create an innovative app.

Ghana,

Ghana, Kenya and Malawi to pilot GSK malaria vaccine from 2018

LONDON, Apr 24 (Reuters) Ghana, Kenya and Malawi will pilot the world's first malaria vaccine from 2018, offering it for babies and children in high-risk areas as part of real-life trials, the World Health Organization said today.

Ghana,

Ghana, Kenya and Malawi to pilot GSK malaria vaccine from 2018

LONDON, Apr 24 (Reuters) Ghana, Kenya and Malawi will pilot the world's first malaria vaccine from 2018, offering it for babies and children in high-risk areas as part of real-life trials, the World Health Organization said today.

Hypertension

Hypertension a silent killer: Dr Jayapraksh Sai

Hyderabad, Apr 22 (UNI) Hypertension is known as a "silent killer" because it has no obvious symptoms and many people are unaware that they have it, Apollo Sugar Clinics Consultant Diabetologist Dr Jayaprakash Sai said.

Hypertension

Hypertension a silent killer: Dr Jayapraksh Sai

Hyderabad, Apr 22 (UNI) Hypertension is known as a "silent killer" because it has no obvious symptoms and many people are unaware that they have it, Apollo Sugar Clinics Consultant Diabetologist Dr Jayaprakash Sai said.

Nano-particle fertilizer could lead to new 'green revolution'

Nano-particle fertilizer could lead to new 'green revolution'

New Delhi, Jan 26 (UNI) Sri Lankan scientists report having developed a simple way to make a benign, more efficient fertilizer – described as nano-particle fertilizer - that could contribute to a second food revolution across the globe.

Broken pebbles offer clues to Palaeolithic funeral rituals

Broken pebbles offer clues to Palaeolithic funeral rituals

New Delhi, Feb 9 (UNI) Humans may have ritualistically "killed" objects to remove their symbolic power, some 5,000 years earlier than previously thought, a new international study of marine pebble tools from an Upper Palaeolithic burial site in Italy suggests.

Fiscal incentives may help reduce emissions in developing countries

Fiscal incentives may help reduce emissions in developing countries

New Delhi, Feb 7 (UNI) Fiscal policies introduced by the Governments in developing countries can have a significant effect on lowering harmful carbon emissions and help countries with fulfilling their commitments under the UNFCCC Paris Agreement, a study has found.

image